<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">5254075</article-id>
    <article-id pub-id-type="pmid">27559154</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btw561</article-id>
    <article-id pub-id-type="publisher-id">btw561</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Sequence Analysis</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Cas-analyzer: an online tool for assessing genome editing results using NGS data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Park</surname>
          <given-names>Jeongbin</given-names>
        </name>
        <xref ref-type="aff" rid="btw561-aff1">1</xref>
        <xref ref-type="author-notes" rid="btw561-FM1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lim</surname>
          <given-names>Kayeong</given-names>
        </name>
        <xref ref-type="aff" rid="btw561-aff2">2</xref>
        <xref ref-type="aff" rid="btw561-aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kim</surname>
          <given-names>Jin-Soo</given-names>
        </name>
        <xref ref-type="aff" rid="btw561-aff2">2</xref>
        <xref ref-type="aff" rid="btw561-aff3">3</xref>
        <xref ref-type="corresp" rid="btw561-cor1"/>
        <!--<email>jskim01@snu.ac.kr</email>-->
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bae</surname>
          <given-names>Sangsu</given-names>
        </name>
        <xref ref-type="aff" rid="btw561-aff1">1</xref>
        <xref ref-type="aff" rid="btw561-aff4">4</xref>
        <xref ref-type="corresp" rid="btw561-cor1"/>
        <!--<email>sangsubae@hanyang.ac.kr</email>-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Valencia</surname>
          <given-names>Alfonso</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <aff id="btw561-aff1"><label>1</label>Department of Chemistry, Hanyang University, Seoul, South Korea</aff>
    <aff id="btw561-aff2"><label>2</label>Center for Genome Engineering, Institute for Basic Science, Seoul, South Korea</aff>
    <aff id="btw561-aff3"><label>3</label>Department of Chemistry, Seoul National University, Seoul, South Korea</aff>
    <aff id="btw561-aff4"><label>4</label>Research Institute for Convergence of Basic Sciences, Hanyang University, Seoul, South Korea</aff>
    <author-notes>
      <corresp id="btw561-cor1">To whom correspondence should be addressed. Email: <email>sangsubae@hanyang.ac.kr</email> or <email>jskim01@snu.ac.kr</email></corresp>
      <fn id="btw561-FM1">
        <p>Present address: Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany</p>
      </fn>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>15</day>
      <month>1</month>
      <year>2017</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2016-08-24">
      <day>24</day>
      <month>8</month>
      <year>2016</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>8</month>
      <year>2016</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>33</volume>
    <issue>2</issue>
    <fpage>286</fpage>
    <lpage>288</lpage>
    <history>
      <date date-type="received">
        <day>31</day>
        <month>5</month>
        <year>2016</year>
      </date>
      <date date-type="rev-recd">
        <day>12</day>
        <month>8</month>
        <year>2016</year>
      </date>
      <date date-type="accepted">
        <day>22</day>
        <month>8</month>
        <year>2016</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author 2016. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2016</copyright-year>
      <license license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btw561.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="sa1">
        <title>Summary</title>
        <p>Genome editing with programmable nucleases has been widely adopted in research and medicine. Next generation sequencing (NGS) platforms are now widely used for measuring the frequencies of mutations induced by CRISPR-Cas9 and other programmable nucleases. Here, we present an online tool, Cas-Analyzer, a JavaScript-based implementation for NGS data analysis. Because Cas-Analyzer is completely used at a client-side web browser on-the-fly, there is no need to upload very large NGS datasets to a server, a time-consuming step in genome editing analysis. Currently, Cas-Analyzer supports various programmable nucleases, including single nucleases and paired nucleases.</p>
      </sec>
      <sec id="sa2">
        <title>Availability and Implementation</title>
        <p>Free access at <ext-link ext-link-type="uri" xlink:href="http://www.rgenome.net/cas-analyzer/">http://www.rgenome.net/cas-analyzer/</ext-link>.</p>
      </sec>
      <sec id="sa3">
        <title>Supplementary information</title>
        <p><xref ref-type="supplementary-material" rid="sup1">Supplementary data</xref> are available at <italic>Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Korea Healthcare technology R&amp;D Project, Ministry for Health &amp; Welfare Affairs</named-content>
        </funding-source>
        <award-id>HI16C1012</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">S.B. and Institute for Basic Science</named-content>
        </funding-source>
        <award-id>IBS-R021-D1</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Programmable nucleases such as zinc finger nucleases (ZFNs), transcription-activator-like effector nucleases (TALENs), and RNA-guided endonucleases derived from CRISPR-Cas9/Cpf1 systems, which are adaptive immune responses in bacteria and archaea, are widely used for genome editing in many research fields including biology, biotechnology, agriculture, and medical science (<xref rid="btw561-B10" ref-type="bibr">Kim and Kim, 2014</xref>). The type II Cas9 nuclease from <italic>Streptococcus pyogenes</italic> (SpCas9) was the first CRISPR nuclease used for genome editing (<xref rid="btw561-B2" ref-type="bibr">Cho <italic>et al.</italic>, 2013</xref>; <xref rid="btw561-B4" ref-type="bibr">Cong <italic>et al.</italic>, 2013</xref>; <xref rid="btw561-B24" ref-type="bibr">Jinek <italic>et al.</italic>, 2013</xref>; <xref rid="btw561-B25" ref-type="bibr">Mali <italic>et al.</italic>, 2013</xref>); since that time, various orthogonal Cas9 nucleases such as StCas9 (<xref rid="btw561-B4" ref-type="bibr">Cong <italic>et al.</italic>, 2013</xref>), NmCas9 (<xref rid="btw561-B6" ref-type="bibr">Hou <italic>et al.</italic>, 2013</xref>) and SaCas9 (<xref rid="btw561-B17" ref-type="bibr">Ran <italic>et al.</italic>, 2015</xref>) have been developed. Recently, putative type V Cpf1 nucleases from <italic>Acidominococcus</italic> and <italic>Lachnospiraceae</italic> were reported to mediate efficient genome editing in human cells (<xref rid="btw561-B8" ref-type="bibr">Kim <italic>et al.</italic>, 2016a</xref>; <xref rid="btw561-B22" ref-type="bibr">Zetsche <italic>et al.</italic>, 2015</xref>) and mice (<xref rid="btw561-B7" ref-type="bibr">Hur <italic>et al.</italic>, 2016</xref>; <xref rid="btw561-B11" ref-type="bibr">Kim <italic>et al.</italic>, 2016b</xref>). Moreover, dimeric CRISPR nucleases such as RNA-guided nickases (<xref rid="btw561-B3" ref-type="bibr">Cho <italic>et al.</italic>, 2014</xref>; <xref rid="btw561-B16" ref-type="bibr">Ran <italic>et al.</italic>, 2013</xref>) and RNA-guided FokI nucleases (<xref rid="btw561-B20" ref-type="bibr">Tsai <italic>et al.</italic>, 2014</xref>), or biochemical improvement of wild-type SpCas9 (<xref rid="btw561-B12" ref-type="bibr">Kleinstiver <italic>et al.</italic>, 2016</xref>; <xref rid="btw561-B19" ref-type="bibr">Slaymaker <italic>et al.</italic>, 2016</xref>) have been developed for genome editing to reduce off-target effects.</p>
    <p>Programmable nucleases introduce DNA double-strand breaks at user-defined target sites in the genome, ultimately inducing targeted gene knockout or knock-in via the cell’s own repair systems [error-prone non-homologous end joining or homology-directed repair (HDR) in the presence of a DNA template, respectively]. The induced mutation rates in cells can be estimated in a straightforward manner by using Surveyor nuclease (<xref rid="btw561-B14" ref-type="bibr">Perez <italic>et al.</italic>, 2008</xref>), the T7 endonuclease I (T7E1) assay (<xref rid="btw561-B9" ref-type="bibr">Kim <italic>et al.</italic>, 2009</xref>), polyacrylamide gel electrophoresis (<xref rid="btw561-B23" ref-type="bibr">Zhu <italic>et al.</italic>, 2014</xref>) or droplet digital PCR (<xref rid="btw561-B13" ref-type="bibr">Nelson <italic>et al.</italic>, 2016</xref>). However, these methods do not allow analysis of mutant sequences and are limited by relatively poor sensitivity. Recently we and other groups have used targeted deep sequencing to detect programmable nuclease-induced mutations with high sensitivity and precision and to analyze mutation patterns (<xref rid="btw561-B1" ref-type="bibr">Baek <italic>et al.</italic>, 2016</xref>).</p>
    <p>However, analysis of next generation sequencing (NGS) data is difficult for many researchers. Although a few web-based tools such as CRISPR-GA (<xref rid="btw561-B5" ref-type="bibr">Güell <italic>et al.</italic>, 2014</xref>), AGEseq (<xref rid="btw561-B21" ref-type="bibr">Xue and Tsai, 2015</xref>) and CRISPResso (<xref rid="btw561-B15" ref-type="bibr">Pinello <italic>et al.</italic>, 2016</xref>) are available, they are inconvenient to use because their web interfaces require a very long time to upload large data files (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material S1</xref>). AGEseq and CRISPResso also support a command-line interface, but they are not accessible to researchers who are not familiar with bioinformatics. To address this issue, we present a web-based tool, Cas-Analyzer that is constructed with a JavaScript-based algorithm; thus, it wholly runs on the client-side so that large amounts of sequencing data do not need to be uploaded to the server. Thanks to the improvements in the newest JavaScript engines in the most recent web browsers (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1</xref>), this tool works in a reasonable time. Currently, Cas-Analyzer supports a variety of nucleases, including single nucleases (SpCas9, StCas9, NmCas9, SaCas9, CjCas9 and AsCpf1/LbCpf1) and paired nucleases (ZFNs, TALENs, Cas9 nickases and dCas9-FokI nucleases). </p>
  </sec>
  <sec>
    <title>2 Implementation</title>
    <sec>
      <title>2.1 File loading</title>
      <p>To use Cas-Analyzer, deep sequencing data are needed, which can be obtained by amplifying the target locus of genome edited cells (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material S2</xref>) followed by NGS. The format of the raw output data is usually Fastq or gzip-compressed, and both data types are acceptable to Cas-Analyzer (<xref ref-type="fig" rid="btw561-F1">Fig. 1A</xref>). For the compressed files, we used a JavaScript library ‘pako’ (<ext-link ext-link-type="uri" xlink:href="http://nodeca.github.io/pako/">http://nodeca.github.io/pako/</ext-link>), which is slightly modified to support blocked gzip files. If users upload paired-end sequencing data, Cas-Analyzer first merges paired-end reads by the JavaScript port of Fastq-join, a part of ea-utils (<ext-link ext-link-type="uri" xlink:href="https://code.google.com/archive/p/ea-utils/">https://code.google.com/archive/p/ea-utils/</ext-link>).</p>
      <fig id="btw561-F1" orientation="portrait" position="float">
        <label>Fig. 1.</label>
        <caption>
          <p>Overview of Cas-Analyzer. <bold>(A)</bold> Uploading NGS data files. Single-end reads, paired-end reads, or already merged sequencing data are allowed. <bold>(B)</bold> Basic information about the query sequences are required for using Cas-Analyzer. <bold>(C)</bold> Indicators used in the analysis step. <bold>(D)</bold> The results are summarized as a table that includes the mutation count and frequency. <bold>(E)</bold> Insertions and deletions are also visualized as graphs. <bold>(F)</bold> All filtered sequences from the input data are aligned with the reference sequence</p>
        </caption>
        <graphic xlink:href="btw561f1"/>
      </fig>
    </sec>
    <sec>
      <title>2.2 Data analysis</title>
      <p>Cas-Analyzer analyzes the uploaded data and calculates mutation frequencies in three steps (<xref ref-type="fig" rid="btw561-F1">Fig. 1B–D</xref>): (i) Cas-Analyzer first finds the cleavage point in the reference sequence for the selected nuclease. Using the given comparison range (R) parameter, Cas-Analyzer defines 12nt of indicator sequences on both sides of the given reference sequence and then selects the valid sequences, which contain both indicators with up to a 1-nt mismatch, from the uploaded data. (ii) For the selected sequences, Cas-Analyzer then counts the recurrent frequency of each sequence and excludes the sequences below the given minimum frequency (n). (iii) Cas-Analyzer finally classifies the filtered sequences into three different groups: ‘insertion’, ‘deletion’ or ‘WT or substitution’ based on comparing the sequence length with the length of the given reference sequence. Optionally, if a WT marker range (r) is given, the short sequence around the cleavage point will be used as the marker of wild-type. If this marker exists in the query sequence, it will always be classified into the ‘WT or substitution’ group regardless of its length. Additionally, if the donor DNA sequence for HDR is given, Cas-Analyzer defines an HDR indicator (&gt;8nt) by comparing the donor sequence with the reference sequence and classifies all query sequences that have the HDR indicator into the ‘HDR’ category. </p>
    </sec>
    <sec>
      <title>2.3 Sequence alignment</title>
      <p>For user convenience, after data analysis is complete, the results (a relatively small amount of data) are aligned to the reference sequence by using a JavaScript ported EMBOSS Needle (<xref rid="btw561-B18" ref-type="bibr">Rice <italic>et al.</italic>, 2000</xref>). The aligned results are categorized by mutation type and sorted in descending order by count. In addition, the position and size of insertions or deletions are depicted as interactive graphs on the results web page (<xref ref-type="fig" rid="btw561-F1">Fig. 1E and F</xref>). </p>
    </sec>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported by a grant of the Korea Healthcare technology R&amp;D Project, Ministry for Health &amp; Welfare Affairs (HI16C1012) to S.B. and Institute for Basic Science (IBS-R021-D1) to J.-S.K.</p>
    <p><italic>Conflict of Interest</italic>: none declared.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sup1">
      <label>Supplementary Data</label>
      <media xlink:href="btw561_supp.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list>
    <title>References</title>
    <ref id="btw561-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baek</surname><given-names>K.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>DNA-free two-gene knockout in Chlamydomonas reinhardtii via CRISPR-Cas9 ribonucleoproteins</article-title>. <source>Sci. Rep</source>., <volume>6</volume>, <fpage>30620</fpage>.<pub-id pub-id-type="pmid">27466170</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>S.W.</given-names></name></person-group><etal>et al</etal> (<year>2013</year>) 
<article-title>Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease</article-title>. <source>Nat. Biotechnol</source>., <volume>31</volume>, <fpage>230</fpage>–<lpage>232</lpage>.<pub-id pub-id-type="pmid">23360966</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>S.W.</given-names></name></person-group><etal>et al</etal> (<year>2014</year>) 
<article-title>Analysis of off-target effects of CRISPR/Cas-derived RNAguided endonucleases and nickases</article-title>. <source>Genome Res</source>., <volume>24</volume>, <fpage>132</fpage>–<lpage>141</lpage>.<pub-id pub-id-type="pmid">24253446</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cong</surname><given-names>L.</given-names></name></person-group><etal>et al</etal> (<year>2013</year>) 
<article-title>Multiplex Genome Engineering Using CRISPR/Cas Systems</article-title>. <source>Science</source>, <volume>339</volume>, <fpage>819</fpage>–<lpage>823</lpage>.<pub-id pub-id-type="pmid">23287718</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Güell</surname><given-names>M.</given-names></name></person-group><etal>et al</etal> (<year>2014</year>) 
<article-title>Genome editing assessment using CRISPR Genome Analyzer (CRISPR-GA)</article-title>. <source>Bioinformatics</source>, <volume>30</volume>, <fpage>2968</fpage>–<lpage>2970</lpage>.<pub-id pub-id-type="pmid">24990609</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>Z.</given-names></name></person-group><etal>et al</etal> (<year>2013</year>) 
<article-title>Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>, <volume>110</volume>, <fpage>15644</fpage>–<lpage>15649</lpage>.<pub-id pub-id-type="pmid">23940360</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hur</surname><given-names>J.K.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>Targeted mutagenesis in mice by electroporation of Cpf1 ribo nucleoproteins</article-title>. <source>Nat. Biotechnol</source>., <volume>34</volume>, <fpage>807</fpage>–<lpage>808</lpage>.<pub-id pub-id-type="pmid">27272385</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B24">
      <mixed-citation publication-type="journal">Jinek,M. <etal>et al</etal> (2013) RNA-programmed genome editing in human cells. <italic>eLife</italic>, <bold>2</bold>, e00471.</mixed-citation>
    </ref>
    <ref id="btw561-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>D.</given-names></name></person-group><etal>et al</etal> (<year>2016a</year>) 
<article-title>Genome-wide analysis reveals specificities of Cpf1 endonucle ases in human cells</article-title>. <source>Nat. Biotechnol</source>., <volume>34</volume>, <fpage>863</fpage>–<lpage>868</lpage>.<pub-id pub-id-type="pmid">27272384</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.J.</given-names></name></person-group><etal>et al</etal> (<year>2009</year>) 
<article-title>Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly</article-title>. <source>Genome Res</source>., <volume>19</volume>, <fpage>1279</fpage>–<lpage>1288</lpage>.<pub-id pub-id-type="pmid">19470664</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J.S.</given-names></name></person-group> (<year>2014</year>) 
<article-title>A guide to genome engineering with programmable nucleases</article-title>. <source>Nat. Rev. Genet</source>., <volume>15</volume>, <fpage>321</fpage>–<lpage>334</lpage>.<pub-id pub-id-type="pmid">24690881</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>Y.</given-names></name></person-group><etal>et al</etal> (<year>2016b</year>) 
<article-title>Generation of knockout mice by Cpf1-mediated gene targeting</article-title>. <source>Nat. Biotechnol</source>., <volume>34</volume>, <fpage>808</fpage>–<lpage>810</lpage>.<pub-id pub-id-type="pmid">27272387</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kleinstiver</surname><given-names>B.P.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects</article-title>. <source>Nature</source>, <volume>529</volume>, <fpage>490</fpage>–<lpage>495</lpage>.<pub-id pub-id-type="pmid">26735016</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B25">
      <mixed-citation publication-type="journal">Mali,P. <etal>et al</etal> (2013) RNA-guided human genome engineering via Cas9. <italic>Science</italic>, <bold>339</bold>, 823–826.</mixed-citation>
    </ref>
    <ref id="btw561-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nelson</surname><given-names>C.E.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy</article-title>. <source>Science</source>, <volume>351</volume>, <fpage>403</fpage>–<lpage>407</lpage>.<pub-id pub-id-type="pmid">26721684</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perez</surname><given-names>E.E.</given-names></name></person-group><etal>et al</etal> (<year>2008</year>) 
<article-title>Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases</article-title>. <source>Nat. Biotechnol</source>., <volume>26</volume>, <fpage>808</fpage>–<lpage>816</lpage>.<pub-id pub-id-type="pmid">18587387</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinello</surname><given-names>L.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>Analyzing CRISPR genome-editing experiments with CRISPResso</article-title>. <source>Nat. Biotechnol</source>., <volume>34</volume>, <fpage>695</fpage>–<lpage>697</lpage>.<pub-id pub-id-type="pmid">27404874</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ran</surname><given-names>F.A.</given-names></name></person-group><etal>et al</etal> (<year>2013</year>) 
<article-title>Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity</article-title>. <source>Cell</source>, <volume>154</volume>, <fpage>1380</fpage>–<lpage>1389</lpage>.<pub-id pub-id-type="pmid">23992846</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ran</surname><given-names>F.A.</given-names></name></person-group><etal>et al</etal> (<year>2015</year>) 
<article-title>In vivo genome editing using Staphylococcus aureus Cas9</article-title>. <source>Nature</source>, <volume>520</volume>, <fpage>186</fpage>–<lpage>191</lpage>.<pub-id pub-id-type="pmid">25830891</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rice</surname><given-names>P.</given-names></name></person-group><etal>et al</etal> (<year>2000</year>) 
<article-title>EMBOSS: the European Molecular Biology Open Software Suite</article-title>. <source>Trends Genet</source>., <volume>16</volume>, <fpage>276</fpage>–<lpage>277</lpage>.<pub-id pub-id-type="pmid">10827456</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slaymaker</surname><given-names>I.M.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>Rationally engineered Cas9 nucleases with improved specificity</article-title>. <source>Science</source>, <volume>351</volume>, <fpage>84</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">26628643</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>S.Q.</given-names></name></person-group><etal>et al</etal> (<year>2014</year>) 
<article-title>Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing</article-title>. <source>Nat. Biotechnol</source>., <volume>32</volume>, <fpage>569</fpage>–<lpage>576</lpage>.<pub-id pub-id-type="pmid">24770325</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>L.J.</given-names></name>, <name name-style="western"><surname>Tsai</surname><given-names>C.J.</given-names></name></person-group> (<year>2015</year>) 
<article-title>AGEseq: analysis of genome editing by sequencing</article-title>. <source>Mol. Plant</source>, <volume>8</volume>, <fpage>1428</fpage>–<lpage>1430</lpage>.<pub-id pub-id-type="pmid">26057235</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zetsche</surname><given-names>B.</given-names></name></person-group><etal>et al</etal> (<year>2015</year>) 
<article-title>Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System</article-title>. <source>Cell</source>, <volume>163</volume>, <fpage>759</fpage>–<lpage>771</lpage>.<pub-id pub-id-type="pmid">26422227</pub-id></mixed-citation>
    </ref>
    <ref id="btw561-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>X.</given-names></name></person-group><etal>et al</etal> (<year>2014</year>) 
<article-title>An efficient genotyping method for genome-modified animals and human cells generated with CRISPR/Cas9 system</article-title>. <source>Sci. Rep</source>., <volume>4</volume>, <fpage>6420</fpage>.<pub-id pub-id-type="pmid">25236476</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
